Navigation Links
Progression of Glaucoma could be controlled with early detection

Glaucoma, according to doctors, is a disease of the eye, which has no early warning signs and many affected patients are unaware they have the disease until it has advanced. And once someone has lost his or her vision from glaucoma, it cannot be regained. Researchers in New York and Sweden, focusing on a previous study called The Early Manifest Glaucoma Trial, conducted a study which looked// at why some patients had their disease progress while others did not. The Early Manifest Glaucoma Trial had included 255 patients from 50 to 80 years old who had early stage glaucoma in at least one eye. Half of the patients were treated with medicines and laser to lower eye pressure and the other half of the patients were not treated. Both the groups were checked by doctors every three months.

The researchers, at the end of six years, found that 53 percent of the patients had progression of their glaucoma. They reported that the progression risk was cut in half in patients who were treated as compared to those who were not treated. They added that other factors were also responsible for progression of the disease, which included patients with higher eye pressure or who had the disease in both eyes or old age. Researchers concluded that each millimeter of mercury that was lowered was associated with a 10 percent decrease in the disease progression. This proved that early treatment of glaucoma can reduce the risk of the disease progressing.


'"/>




Page: 1

Related medicine news :

1. Shyness Linked To HIV Progression
2. Delaying The Progression Of Alzheimer’s Disease
3. Stopping The Progression Of Parkinsons Disease
4. Contact Lenses Found To Slow Progression Of Myopia in Kids
5. Arithmetic Skills Found To Diminish With Progression Of Alzheimer’s Disease
6. Slowing Down The Progression Of Alzheimer’s Disease
7. Slowing Down The Progression Of Tumour Cells With Omega-6 Fatty Acids
8. Change In Diet May Slow The Progression Of Prostate Cancer
9. Broccoli Found to Block Cancer Progression In Both Animal and Human Studies
10. Pomegranates Found To Slow Prostate Cancer Progression
11. Macrophage Inhibitory Factor Causes Multiple Sclerosis Progression
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... BASKING RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... second annual Holly Day Market. Featuring a collection of specialty vendors and unique items ... myriad of personalized and quality-focused health and wellness services offered by the VNA. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids ... Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, ... run is geared towards children of all ages; it is a non-competitive, non-timed event, ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: